Delayed development of obliterative bronchiolitis syndrome with OKT3 after unilateral lung transplantation: A plea for multicenter immunosuppressive trials

Chest

Volumn 109, Issue 4, 1996, Pages 870-873

  Ross, David J ^a,b   Jordan, Stanley C ^a   Nathan, Steven D ^a   Kass, Robert Mace ^a   Koener, Spencer K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

chronic allograft rejection; immunosuppression; obliterative bronchiolitis

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; OKT 3; PREDNISONE;

ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FIBEROPTIC BRONCHOSCOPY; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LATENT PERIOD; LUNG TRANSPLANTATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPIROMETRY; STAGING; VIRUS PNEUMONIA;

EID: 0029917039     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.4.870     Document Type: Article

References (23)

1. Kave MP. The Registry of The International Society for Heart and Lung Transplantation: tenth official report - 1993. J Heart Lung Transplant 1993; 12:541-48
2. Burke CM, Theodore J, Dawkins KD, et al. Posttransplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest 1984; 86:824-29
3. Griffith BP, Paradis IL, Zeevi A, et al. Immunologically mediated disease of the airways after pulmonary transplantation. Ann Surg 1988; 208:371
4. Yousem SA, Burke CM, Billingham ME. Pathologic pulmonary alterations in long-term human heart-lung transplantation. Hum Pathol 1985; 16:911
5. Zeevi A, Fung JJ, Paradis IL. Bronchoalveolar lavage macrophage lymphocyte reactivity in heart-lung recipients. Transplant Proc 1987; 19:2537
6. Scott JP, Higgenbottam TW, Clelland CA, et al. Natural history of chronic rejection in heart-lung transplant recipients. J Heart Transplant 1990; 9:510
7. Yousem SA, Paradis IL, Dauber JH, et al. Efficacy of transbronchial lung biopsy in the diagnosis of bronchiolitis obliterans in heart-lung transplant recipients. Transplantation 1989; 47:893-95
8. Kramer MR, Sibley R, Stoehr C, et al. Transbronchial lung biopsies have low yield in the detection of post-heart-lung and lung transplantation obliterative bronchiolitis [abstract]. Am Rev Respir Dis 1992; 145-4(pt 2):A:699
9. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993; 12:713-16
10. Otulana BA, Higgenbottam T, Ferrari L, et al. The use of home spirometry in detecting acute lung rejection and infection following heart-lung transplantation. Chest 1990; 97:353-57
11. Yousem SA, Berry GJ, Brunt EM, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. J Heart Transplant 1990; 9:593-601
12. Keenan RJ, Lega ME, Dummer JS, et al. Cytomegalovirus serlogic status and post-operative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 1991; 51:433-38
13. Sharples LD, Scott JP, Dennis C, et al. Risk factors for survival following combined heart-lung transplantation. Transplantation 1994; 57:218-23
14. Festenstein H, Banner N, Smith J, et al. The influence of HLA matching and lymphocytotoxic antibody status in heart-lung allograft recipients receivingcyclosporine and azathioprine. Transplant Proc 1989; 21:797-98
15. Iwaki Y, Yoshida Y, Griffith B. Brief communications: HLA matching effect in lung transplantation. Transplantation 1993; 56: 1528-64
16. Scott JP, Higgenbottam TW, Sharples L, et al. Risk factors for obliterative bronchiolitis in heart-lung transplantation recipients. Transplantation 1991; 51:813-17
17. Scott JP, Higgenbottam TW, Cleeland CA, et al. Natural history of chronic rejection in heart-lung transplant recipients. J Heart Transplant 1990; 9:510-15
18. Yousem SA, Dauber JA, Keenan R, et al. Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? Transplantation 1991; 52:306-09
19. Hanto DW, Jendrisak MD, So SKS, et al. Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Transplantation 1994; 57:377-84
20. Cole EH, Cattran DC, Farewell VT, et al. A comparison of rabbit antithymocyte serum and OKT3 as prophylaxis against renal allograft rejection. Transplantation 1994; 57:60-7
21. Demertzis S, Ruschult H, Zink C, et al. The impact of prophylactic post-operative treatment with T-cell antibodies on the incidence of obliterative bronchiolitis. J Heart Lung Transplant 1994; 13(pt 1 of 2):S43
22. Reinsmoen NL, Bolman RM, Savik K, et al. Are multiple immunopathogenic events occuring during the development of obliterative bronchiolitis and acute rejection? Transplantation 1993; 55:1040-44
23. Nathan SD, Ross DJ, Belman MJ, et al. Bronchiolitis obliterans in single-lung transplant recipients. Chest 1995; 107:967-72